European equities have started the week with a positive trading day, but with investors still reeling from one of the wildest weeks for markets on record.

From Oscar-winning blockbusters to cult favorites and family-friendly animations, Freeview and Freely offer a packed lineup of films this April. Whether you’re in the mood for action, mystery, or a ...

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

When taken for 40 weeks for type 2 diabetes, orforglipron resulted in an average loss of 16 pounds, or about 7.9% of the patient's body weight, at the highest dose. HealthDay News — A new pill ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

The show didn’t glamorize it but didn’t shame it. That small white pill became a shorthand for everything we’re collectively suppressing: anxiety, overstimulation, and the quiet desperation ...